Form 4: TransMedics Group Executive Tamer Khayal Exercises Options and Sells Shares

Sentiment:

SEC Form 4


Tamer Khayal, Chief Commercial Officer of TransMedics Group, exercised stock options and sold shares of common stock on July 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 1, 2024, Tamer Khayal, the Chief Commercial Officer of TransMedics Group, Inc., engaged in transactions involving the company's common stock.
  • Khayal exercised stock options to acquire 1,458 shares at $38.46, 417 shares at $66.10, and 1,083 shares at $13.28.
  • Concurrently, Khayal sold 110 shares at a weighted average price of $149.57, 1,000 shares at $150.70, 1,106 shares at $151.33, 582 shares at $152.53, and 160 shares at $153.48.
  • These transactions were executed under a pre-existing Rule 10b5-1 trading plan established on September 6, 2023.
  • Following these transactions, Khayal directly owns 20,843 shares of TransMedics Group, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, indicating a neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company executives.

Key Dates

DateDescription
2023-09-06Date of establishment of Rule 10b5-1 trading plan
2024-02-20Full vest date of stock options
2024-02-22Full vest date of stock options
2024-02-24Full vest date of stock options
2024-07-01Date of transactions (option exercise and share sales)
2031-02-24Expiration date of stock options
2032-02-22Expiration date of stock options
2033-02-20Expiration date of stock options
2024-07-03Date of report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.